ArticleJournal of gastrointestinal oncology2022

A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer.

Samrat M Sanghvi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.